共 142 条
- [41] Miyanari N(2011)Frailty, inflammation, and immunity Aging Dis 26 264-522
- [42] Morito A(2019)Physical activity and exercise during preoperative pancreatic cancer treatment Support Care Cancer 20 1243-1773
- [43] Rockwood K(2019)Clinical benefit of preoperative exercise and nutritional therapy for patients undergoing hepato-pancreato-biliary surgeries for malignancy Ann Surg Oncol 35 515-942
- [44] Song X(2020)Prehabilitation prior to surgery for pancreatic cancer: a systematic review Pancreatology 38 1763-413
- [45] MacKnight C(2017)Neoadjuvant therapy followed by resection versus upfront resection for resectable pancreatic cancer: a propensity score matched analysis J Clin Oncol 154 932-108
- [46] Rouge-Bugat ME(2020)Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial J Clin Oncol 270 400-undefined
- [47] Gerard S(2019)Outcomes of primary chemotherapy for borderline resectable and locally advanced pancreatic ductal adenocarcinoma JAMA Surg 4 100-undefined
- [48] Balardy L(2019)Survival outcomes associated with clinical and pathological response following neoadjuvant FOLFIRINOX or gemcitabine/nab-paclitaxel chemotherapy in resected pancreatic cancer Ann Surg undefined undefined-undefined
- [49] Miyata T(2020)Neoadjuvant treatment for resectable pancreatic adenocarcinoma: What is the best protocol? Ann Gastroenterol Surg undefined undefined-undefined
- [50] Hayashi H(undefined)undefined undefined undefined undefined-undefined